For instance, Li et al. revealed that SHP-1 hypermethylation was involved in CML evolution through the regulation of the BCR::ABL1, AKT, MAPK, MYC and JAK2/STAT5 signaling pathways [18]. The gene discussed is JAK2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.